Delivra Health Brands Inc. (TSE:DHB) has released an update.
Delivra Health Brands Inc. has reported significant financial growth with a 36% increase in net revenue and a substantial improvement in adjusted EBITDA, reaching $845, for the first nine months of fiscal 2024. The company attributes this success to higher sales volumes in their Dream Water and LivRelief brands in the U.S. and Canada, as well as effective cost management leading to a higher gross profit margin of 52%. Delivra Health is optimistic about continuing this positive trajectory into fiscal 2025.
For further insights into TSE:DHB stock, check out TipRanks’ Stock Analysis page.
